AGP Executive Report
Last update: 12 hours agoDEA Rescheduling Hearing: A long-awaited U.S. DEA hearing on proposed marijuana rescheduling (Schedule I to Schedule III) kicks off Monday, with supporters arguing it better matches medical practice and opponents warning it could expand the commercial market. CBD Legal Pressure: A federal appeals court upheld the DEA’s position that CBD is a Schedule 1 controlled substance, meaning hemp-derived CBD sales must follow state rules or risk federal conflict. Hemp Industry Setback: The same DEA-linked fight has hemp producers vowing to appeal, keeping uncertainty high for retailers and brands. Nigeria Drug Enforcement: NDLEA seized 4,959kg of Canadian “loud” cannabis worth ₦12.4bn at Lagos’s Apapa Port and arrested a China-bound businesswoman with 7.5kg cocaine. Local Drug Harm Push: In Whangārei, a woman is campaigning to stop meth pipes being sold openly in shops, citing legal confusion and youth exposure. Cannabis Business Moves: New York’s first approved cannabis growers showcase drew local farmers, while one town voted against allowing similar events. Industry Capital Signals: Curaleaf CEO Boris Jordan says institutional equity investors are finally willing to talk with cannabis operators, hinting at a potential shift in funding conversations. Wellness Branding: Jamaica’s JACANA launched a Caribbean Wellness Platform, pitching botanical products plus nature-based experiences for the booming wellness-tourism market.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.